Opaleye Management Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$5,740,000
-30.9%
500,000
+2.0%
2.14%
+1.4%
Q3 2018$8,305,000
+15.8%
490,000
-3.0%
2.11%
+13.8%
Q2 2018$7,171,000
-29.5%
505,000
-5.6%
1.86%
-36.1%
Q1 2018$10,165,000
+6.9%
535,000
-7.8%
2.91%
-4.6%
Q4 2017$9,512,000
+9.3%
580,0000.0%3.05%
-1.0%
Q3 2017$8,700,000
+70.5%
580,0000.0%3.08%
+44.3%
Q2 2017$5,104,000
+69.0%
580,000
-0.2%
2.13%
+41.8%
Q1 2017$3,021,000
+147.6%
581,000
+45.2%
1.50%
+109.2%
Q4 2016$1,220,000
+122.6%
400,000
+566.7%
0.72%
+214.0%
Q4 2015$548,00060,0000.23%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders